Relapse Leukemia: Clinical Trials

2 trials for Relapse Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Unknown 1

Follow Relapse Leukemia: new trials by email Literature Review of Relapse Leukemia trials Research Report on Relapse Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML
MTBF regimen - Relapse Leukemia, Refractory Acute Myeloid Leukemia
Not applicableNot yet recruitingFirst Affiliated Hospital Xi'an Jiaotong University372024-05-012024-04-26
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
blood sample, bone marrow sample - Relapse Leukemia, Allogeneic Stem Cell Transplantation
Not applicableUnknownCentral Hospital, Nancy, France1042019-09-012019-05-28

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Blood Specimen Collection (1)  ·  Busulfan (1)  ·  Thiotepa (1)  ·  fludarabine (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)

Top investigators

Xiaoning Wang, M.D. (1)